Latest news

Showing 1-6 of 6
23 October 2002
Interim Report 3, 2002

Nobel Biocare is experiencing an increasing currency-adjusted growth trend. Total sales amounted to SEK 2 075.8 million (11.5% currency-adjusted growth). In Q3 2002, sales amounted to SEK 618.0 million (12.8% currency-adjusted growth).

14 August 2002
Interim Report 2, 2002

Total sales increased by 11% (11% currency adjusted) to SEK 1 457.8 million. In Q2 2002, sales increased by 7% (11% currency adjusted) to SEK 728.9 million. Sales performance in Q2 was not impacted by any price changes.

12 July 2002
After the extended acceptance period ending July 9 2002, Nobel Biocare Holding AG now owns approximately 99% of the shares of Nobel Biocare AB

Owning 99% of the shares in Nobel Biocare AB, Nobel Biocare Holding AG completes the offer to acquire all the outstanding shares of Nobel Biocare AB.

25 April 2002
Nobel Biocare Annual General Meeting 2002

The Annual General Meeting on April 24, 2001, approved a dividend of SEK 3.00 or a total of SEK 76,065,000. The record day for this dividend will be 29 April 2002.

24 April 2002
Interim Report 1, January-March 2002

Sales increased by 16% to SEK 728.9 million (630.5). Operating income increased by 48% to SEK 143.6 million.

7 February 2002
Full Year Report 2001

Sales increased by 26% to SEK 2 663.2 million (2 109.5). Sales in the fourth quarter amounted to SEK 754.1 million (634.8).

Showing 1-6 of 6 

Media contact

Süha Demokan

Süha Demokan

Vice President Investor & Corporate Relations

Nobel Biocare Management AG 
P.O. Box
CH - 8058 Zurich-Airport
Switzerland

+41 43 211 42 30

+41 79 430 81 46

+41 43 211 58 11

Give us your feedback!

Summarize your comments
Email